Janice Shipe-Spotloe

721 total citations
16 papers, 547 citations indexed

About

Janice Shipe-Spotloe is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Janice Shipe-Spotloe has authored 16 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Immunology. Recurrent topics in Janice Shipe-Spotloe's work include Immunotherapy and Immune Responses (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and CAR-T cell therapy research (5 papers). Janice Shipe-Spotloe is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and CAR-T cell therapy research (5 papers). Janice Shipe-Spotloe collaborates with scholars based in United States and Australia. Janice Shipe-Spotloe's co-authors include John M. Kirkwood, Howard Edington, Ahmad A. Tarhini, Uma N. M. Rao, D.M. Jukic, Stephanie R. Land, Stergios Moschos, Sandra Donnelly, Sanjiv S. Agarwala and Catherine Bender and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Janice Shipe-Spotloe

16 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janice Shipe-Spotloe United States 9 368 259 245 39 36 16 547
Viviana Bozón United States 11 525 1.4× 377 1.5× 195 0.8× 32 0.8× 30 0.8× 28 662
Darab Kamanabrou Germany 6 372 1.0× 139 0.5× 305 1.2× 17 0.4× 24 0.7× 7 517
Christine Longvert France 12 353 1.0× 106 0.4× 233 1.0× 17 0.4× 40 1.1× 34 525
A. Ribas United States 14 478 1.3× 191 0.7× 286 1.2× 43 1.1× 45 1.3× 41 598
Virginia Picasso Italy 12 400 1.1× 197 0.8× 314 1.3× 29 0.7× 56 1.6× 16 661
Matthew Winans United States 7 245 0.7× 209 0.8× 276 1.1× 46 1.2× 89 2.5× 7 633
Antonio Cusmai Italy 11 292 0.8× 138 0.5× 197 0.8× 30 0.8× 109 3.0× 28 577
Charlotte Lemech Australia 16 389 1.1× 146 0.6× 262 1.1× 71 1.8× 81 2.3× 63 695
Giuseppe Dastoli Italy 15 284 0.8× 154 0.6× 251 1.0× 61 1.6× 37 1.0× 23 806
C. A. Bulanhagui United States 10 924 2.5× 747 2.9× 200 0.8× 64 1.6× 40 1.1× 18 1.1k

Countries citing papers authored by Janice Shipe-Spotloe

Since Specialization
Citations

This map shows the geographic impact of Janice Shipe-Spotloe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice Shipe-Spotloe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice Shipe-Spotloe more than expected).

Fields of papers citing papers by Janice Shipe-Spotloe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice Shipe-Spotloe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice Shipe-Spotloe. The network helps show where Janice Shipe-Spotloe may publish in the future.

Co-authorship network of co-authors of Janice Shipe-Spotloe

This figure shows the co-authorship network connecting the top 25 collaborators of Janice Shipe-Spotloe. A scholar is included among the top collaborators of Janice Shipe-Spotloe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice Shipe-Spotloe. Janice Shipe-Spotloe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tarhini, Ahmad A., Howard Edington, Lisa H. Butterfield, et al.. (2012). Neoadjuvant ipilimumab in locally/regionally advanced melanoma: Clinical outcome and immune monitoring.. Journal of Clinical Oncology. 30(15_suppl). 8533–8533. 5 indexed citations
2.
Moschos, Stergios J., Ahmad A. Tarhini, Thomas F. Gajewski, et al.. (2012). Phase II study of the anti-ganglioside GD3 mouse/human chimeric antibody KW2871 combined with high dose interferon-a2b in patients with metastatic melanoma.. Journal of Clinical Oncology. 30(15_suppl). 8547–8547. 1 indexed citations
3.
Tarhini, Ahmad A., Paul Frankel, Kim Margolin, et al.. (2011). Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin. Clinical Cancer Research. 17(20). 6574–6581. 62 indexed citations
4.
Tawbi, Hussein, Liza C. Villaruz, Ahmad A. Tarhini, et al.. (2011). Inhibition of DNA repair with MGMT pseudosubstrates: phase I study of lomeguatrib in combination with dacarbazine in patients with advanced melanoma and other solid tumours. British Journal of Cancer. 105(6). 773–777. 31 indexed citations
5.
Tarhini, Ahmad A., Howard Edington, Lisa H. Butterfield, et al.. (2011). Neoadjuvant ipilimumab in patients with stage IIIB/C melanoma: Immunogenicity and biomarker analysis.. Journal of Clinical Oncology. 29(15_suppl). 8536–8536. 9 indexed citations
6.
Tarhini, Ahmad A., Paul Frankel, Kim Margolin, et al.. (2009). Phase II study of aflibercept (VEGF trap) in recurrent inoperable stage III or stage IV melanoma of cutaneous or ocular origin. Journal of Clinical Oncology. 27(15_suppl). 9028–9028. 17 indexed citations
7.
Wang, Wenjun, Howard Edington, Uma N. M. Rao, et al.. (2008). STAT3 as a Biomarker of Progression in Atypical Nevi of Patients with Melanoma: Dose–Response Effects of Systemic IFNα Therapy. Journal of Investigative Dermatology. 128(8). 1997–2002. 17 indexed citations
8.
Moschos, Stergios, Howard Edington, Stephanie R. Land, et al.. (2006). Neoadjuvant Treatment of Regional Stage IIIB Melanoma With High-Dose Interferon Alfa-2b Induces Objective Tumor Regression in Association With Modulation of Tumor Infiltrating Host Cellular Immune Responses. Journal of Clinical Oncology. 24(19). 3164–3171. 191 indexed citations
9.
Tawbi, Hussein A., Ahmad A. Tarhini, Stergios J. Moschos, et al.. (2006). Phase I trial of lomeguatrib (PN) combined with dacarbazine (DTIC) for treatment of patients with melanoma and other solid tumors: Initial results. Journal of Clinical Oncology. 24(18_suppl). 8016–8016. 2 indexed citations
10.
Moschos, Stergios J., Howard Edington, Uma N. M. Rao, et al.. (2005). High dose Interferon-α2b (HDI): Toxicity, response, and predictive markers in a neoadjuvant trial for regional lymph node metastatic melanoma. Journal of Clinical Oncology. 23(16_suppl). 7517–7517. 7 indexed citations
11.
Robertson, M. J., John M. Kirkwood, Theodore F. Logan, et al.. (2005). Phase I study of recombinant human IL-18 (rhIL-18) administered as five daily intravenous infusions every 28 days in patients with solid tumors. Journal of Clinical Oncology. 23(16_suppl). 2513–2513. 4 indexed citations
12.
Zarour, Hassane M., Maja Mandić, Pavol Kudela, et al.. (2005). Randomized Phase I-II Study of Vaccination With CpG 7909, Montanide ISA 720 and NY-ESO-1 Peptides for Patients With Stage III/IV Melanoma and NY-ESO-1+ Tumors: An Interim Analysis. Journal of Immunotherapy. 28(6). 661–662. 1 indexed citations
13.
Agarwala, Sanjiv S., William E. Gooding, Gina D’Angelo, et al.. (2004). Phase II trial of high-dose bolus IL-2 in patients with metastatic melanoma (mm) who have previously failed biochemotherapy (BCT). Journal of Clinical Oncology. 22(14_suppl). 7512–7512. 1 indexed citations
14.
Kirkwood, John M., Catherine Bender, Sanjiv S. Agarwala, et al.. (2002). Mechanisms and Management of Toxicities Associated With High-Dose Interferon Alfa-2b Therapy. Journal of Clinical Oncology. 20(17). 3703–3718. 145 indexed citations
15.
Kirkwood, John M., R. Mascari, Howard Edington, et al.. (2000). Analysis of therapeutic and immunologic effects of R24 anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma. Cancer. 88(12). 2693–2702. 33 indexed citations
16.
Wang, Yi‐Ping, Uma Rao, R. Mascari, et al.. (1996). Molecular analysis of melanoma precursor lesions.. PubMed. 7(12). 1733–40. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Viviana Bozón Breakdown of academic impact, for papers by Darab Kamanabrou Breakdown of academic impact, for papers by Christine Longvert Breakdown of academic impact, for papers by A. Ribas Breakdown of academic impact, for papers by Virginia Picasso Breakdown of academic impact, for papers by Matthew Winans Breakdown of academic impact, for papers by Antonio Cusmai Breakdown of academic impact, for papers by Charlotte Lemech Breakdown of academic impact, for papers by Giuseppe Dastoli Breakdown of academic impact, for papers by C. A. Bulanhagui
Rankless by CCL
2026